Skip links
Case Study

A robust, actionable strategy for an exceptional EU launch

Expert healthcare consultancy to a global pharmaceutical company, to develop an EU launch strategy and associated plans for an asset being developed in multiple indications.

The Challenge

Our client, a global launch team, needed help cultivating an EU launch strategy for an asset being developed in multiple indications.

Why Uptake?

The Uptake team had the capability to rigorously review the team’s current global launch strategy in light of new EU payor research, and provide strategic options for the EU launch.

Uptake’s deep planning expertise was then needed to generate a corresponding action plan for each of these strategic options.

An approach that inspires

The Uptake team developed a well-structured approach to ensure a successful EU launch. We leveraged our many combined years of industry knowledge to lay the groundwork for establishing a viable launch strategy.

Uptake delivered:

Interviews with members of the Global cross-functional launch team and key EU markets to identify functional perspectives and critical issues for the EU launch.

Potential regulatory filing and reimbursement strategy scenarios and highlighted the pros and cons for each.

A Global and EU cross-functional workshop with 40 participants to:

  1. align on key considerations for each scenario and outline which scenarios to dismiss
  2. identify key decision gates and outstanding data requirements for the remaining scenarios and review and refine planned activities for these scenarios by function

Assumptions for the commercial evaluation modelling of each remaining scenario.

An executive leadership presentation detailing progress, strategic options, and investment required for a successful EU launch.

Delivering positive outcomes

Uptake’s methodical, detailed approach made a huge impact on our client’s business:

Informed decisions

Recognition of all the critical factors needed to inform EU launch decision making.

Robust evaluation

Complex problems were navigated by determining strategic options and a financially evaluated recommendation.

Increased agility

Functional launch planning activities were aligned behind high probability scenarios for increased launch agility.

Client Feedback

Our collaboration in their words.

The Global Executive team endorsed the recommended EU launch strategy and accompanying incremental investment request

91% of the workshop participants reported that they now had greater awareness of the considerations that underpin the EU launch strategy.

86% of workshop participants agreed that the facilitators were knowledgeable and guided participants through the workshop process effectively.

Are you looking for a launch partner with deep experience?

Our expert healthcare consultants have provided many of the world’s leading pharmaceutical and biotech companies with the strategies, tools, and capabilities to drive uptake.

Get in touch for a conversation about your current challenges.

Explore all Case Studies